VitaSpring Biomedical Co. (VSBC) Stock Analysis & Winston Score

Winston Score History

VitaSpring Biomedical Co. Ltd. is a small biotechnology company focused on healthcare and biomedical products. The company operates in the life sciences space, developing or distributing products aimed at medical or wellness applications. Given its very early-stage profile and near-zero revenue metrics, it appears to be in a pre-commercial or early commercial phase.

The company generates little to no meaningful revenue at this stage, as reflected by its 0% gross and operating margins. It likely operates primarily in Asian markets, given its corporate structure, though its exact geographic footprint is limited in public disclosure. The unusually high reported ROIC figure is likely a data artifact rather than a sign of strong capital efficiency, and investors should treat it with caution. The central risk for VitaSpring is its ability to develop a viable, scalable product and secure enough funding to reach commercial operations before cash resources run out.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

YoY Growth Rate

EPS data limited

Insider Activity

52.8%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$2,084 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

VitaSpring Biomedical Co. has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

Data not available

Profit after running costs

Operating Margin

N/A

Data not available

Return on the money invested

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial